New SGS biopharmaceutical testing capabilities in Illinois

11 Sep 2018

The new services will focus on quality control analysis and stability testing of biopharmaceuticals.

SGS is investing more than $1.7 million to expand its North American biopharmaceutical testing capabilities at its Lincolnshire facility in the northern suburbs of Chicago, Illinois, USA. Installation of all equipment will be completed in Q1 2019.

New SGS biopharmaceutical testing capabilities in Illinois
SGS Lincolnshire.

The investment, both in expertise and equipment, will extend the biopharmaceutical testing services offered by SGS’s current US and Canadian Life Science facilities. Using state-of-the-art methodologies and instrumentation, the new services will focus on quality control analysis and stability testing of biopharmaceuticals.

The site currently offers a wide range of analytical services, and has adapted 313 m3 of stability storage to meet the lower temperature regulatory requirements for peptides and proteins. This additional investment will allow SGS to offer greater capacity for GMP biologics testing capabilities in North America to better serve its biopharmaceutical clients.

“Because of its strategic geographic location, in what is a rich cluster of biopharmaceutical companies, strengthening the capabilities at the Lincolnshire laboratory will allow SGS to act as a local partner for innovators looking for expertise in biopharmaceutical analysis,” said James Nokes, Vice President of US Agriculture, Food and Life at SGS. “SGS maintains its commitment to invest in its network of laboratories to offer integrated solutions, and evolve for both the local and global needs of its clients.”

This new development is part of a wider program of investments in the company’s global laboratory network. In August 2017, SGS announced a 50% expansion of its Lincolnshire laboratory, growing its footprint to nearly 58,000 sq. ft. Increases in extractables and leachables capabilities have also taken place at Fairfield, New Jersey, and Shanghai, China; while French facilities at Poitiers and Villeneuve-la-Garenne have seen investment in bioanalytical capabilities and elemental analysis respectively.

Read More

Related news

Chemspace and LabNetwork collaborate to extend access to chemical databases

Chemspace and LabNetwork collaborate to extend access to chemical databases

14 Feb 2019

Collaboration provides drug discovery researchers access to European distribution and local support for library of in-stock and on-demand compounds.

Read more 
SGS to conduct its first malaria human challenge trial in Belgium

SGS to conduct its first malaria human challenge trial in Belgium

13 Feb 2019

The advanced candidate compound undergoing the trial has demonstrated potential to target malaria parasites before they have a chance to establish the symptoms of malaria.

Read more 
Post-EU FMD deadline - 'business as usual'?

Post-EU FMD deadline - 'business as usual'?

12 Feb 2019

Partner connectivity will be an immediate and ongoing challenge beyond the deadline and several pharma companies are likely to break agreements with current suppliers through breach of contract clauses.

Read more 
BASF opens Application Technology Laboratory for personal care in Nigeria

BASF opens Application Technology Laboratory for personal care in Nigeria

11 Feb 2019

Local competence in application and formulation technology for sub-Saharan African personal care market.

Read more 
FDA approves first Nanobody-based medicine for adults with aTTP

FDA approves first Nanobody-based medicine for adults with aTTP

10 Feb 2019

Cablivi is the first US approval for Sanofi's new rare blood disorders franchise.

Read more 
Pharmapack Europe 2019 Award Winners

Pharmapack Europe 2019 Award Winners

7 Feb 2019

Awards showcased a wide range of industry-changing discoveries in drug delivery, packaging and automation.

Read more 
Brexit - the EU FMD's painful problem

Brexit - the EU FMD's painful problem

7 Feb 2019

Teething problems are no stranger to the implementation of new regulations, but with the EU FMD, Brexit came like a set of wisdom teeth – late, painful and problematic.

Read more 
New series of advanced freeze dryers

New series of advanced freeze dryers

6 Feb 2019

The LyoConstellation series allows the development of highly aggressive cycles and the mapping of the furthest reaches of theoretical design space for a formulation.

Read more 
Hitachi Chemical to acquire apceth Biopharma

Hitachi Chemical to acquire apceth Biopharma

5 Feb 2019

Acquisition will strengthen Hitachi's presence in the second-largest cell and gene therapy market in the world.

Read more 
FDA approves first generic Advair Diskus

FDA approves first generic Advair Diskus

4 Feb 2019

Mylan's Wixela Inhub is the first FDA-approved therapeutically equivalent generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for certain patients with asthma or COPD.

Read more